Scientists who cloned Dolly the Sheep developing a new treatment for coronaviruses using immune cells

0
165


Scientists responsible for the cloning of Dolly the Sheep are said to be in talks with the government over a potential treatment for Covid-19 using immune cells from young and healthy volunteers.

Researchers at TC Biopharm near Glasgow have used the new therapy – which uses transfusions of immune-boosting cells – to successfully treat cancer.

The Daily Telegraph has indicated that it now hopes it will also work against the coronavirus and is in talks with the government to test therapy for this purpose.

It is hoped that therapy will be available in NHS hospitals by July.

Dolly the sheep photographed in 2002. Its creation was fundamental to stem cell research and

Dolly the sheep photographed in 2002. Its creation was fundamental to stem cell research and “opened up previously unimaginable possibilities” in biology and medicine, scientists said.

Dolly the Sheep was cloned in 1996 and revealed to the world in 1997. Her case has been studied by scientists for more than 20 years.

Dolly the Sheep was cloned in 1996 and revealed to the world in 1997. Her case has been studied by scientists for more than 20 years.

Dr. Brian Kelly, Senior Strategic Medical Advisor at TC Biopharm, told the newspaper, “One of the main challenges in fighting viral infection is to develop something that will attack infected cells, not normal cells.

HOW DOLLY WAS CREATED

Dolly the sheep was born at the Roslin Institute in Edinburgh in July 1996, living for 14 years before dying on February 14, 2003.

Dolly was the only surviving lamb in 277 cloning attempts and was created from a breast cell taken from a six-year-old Finn Dorset sheep.

It was created using a technique called nuclear transfer of somatic cells.

The innovative technique used by Roslin’s team was to transfer the nucleus of an adult cell into an unfertilized egg from which the nucleus had been removed.

An electric shock stimulated the hybrid cell to begin to divide and generate an embryo, which was then implanted in the womb of a surrogate mother.

Dolly was the first clone successfully produced from a cell taken from an adult mammal.

Dolly’s creation showed that genes in the nucleus of a mature cell are always able to return to an embryonic totipotent state – which means that the cell can divide to produce all of the difference cells in an animal.

His case continued to inspire research more than 20 years after its revelation to the world.

“So the solution we found was to look at the body’s natural defenses against viral infection.

“There is a very small subset of gamma delta T cells that are the first line of defense against viral infections.

“In patients who have successfully fought a viral infection, they have developed their own immune systems and this persists to keep them from becoming infected again. “

Donor T cells differ from normal immune cells in that they do not identify invaders in the body based on exotic protrusions on the surface of the cells, but by detecting the unusual metabolism of viruses.

When donor cells detect a virus, they begin to destroy it while signaling it to the rest of the immune system as a foreign intrusion requiring eradication.

Dr. Kelly said that with this approach, even if the virus mutated and returned to a body, the infusion exercise could be repeated and would still work.

Doctors can infuse cells with a patient in a single hour treatment, TC Biopharm already having a license to perform such treatments.

TC Biopharm was founded in Edinburgh in 1996 by Angela Scott, who was part of the team that cloned Dolly the Sheep. Dolly herself suffered from virus-induced lung disease.

Since her death in 2003, Dolly has been exhibited at the National Museum of Scotland in Edinburgh. Although she died 14 years ago, four identical clones of her still live

Since her death in 2003, Dolly has been exhibited at the National Museum of Scotland in Edinburgh. Although she died 14 years ago, four identical clones of her still live

Dr. Brian Kelly, TC Biopharm's Senior Strategic Medical Advisor, said the main challenge in fighting viral infection is to develop something that will attack infected cells.

Dr. Brian Kelly, TC Biopharm’s Senior Strategic Medical Advisor, said that the main challenge in fighting viral infection is to develop something that will attack infected cells.

Dolly the Sheep continued to inspire scientific research more than 20 years after its revelation to the world in 1997, born in 1996.

Its creation was fundamental to stem cell research and “opened up previously unimaginable possibilities” in biology and medicine, scientists have already said.

She was named after Dolly Parton, the curvy country and western singer, because the adult cell used came from a mammary gland.

His birth sparked a furious debate over the ethics of cloning – a row that deepened with the claims of human cloning.

Dolly was somewhat of a medical wonder as the only surviving lamb from 277 cloning attempts and was created from an udder cell taken from a six-year-old Finn Dorset sheep.

The innovative technique used by Roslin’s team was to transfer the nucleus of an adult cell into an unfertilized egg from which the nucleus had been removed.

An electric shock stimulated the hybrid cell to begin to divide and generate an embryo, which was then implanted in the womb of a surrogate mother.

Dolly normally raised herself twice with a Welsh ram called David, and gave birth to four lambs.

She suffered from arthritis and viral lung disease and died on February 14, 2003.

How can immune cell therapy work against coronavirus?

Researchers at TC Biopharm, a cancer treatment company in Glasgow, say the new therapy uses transfusions of immune-boosting cells that could also fight the coronavirus.

Scientists are aiming to develop something that will attack cells that have been infected with Covid-19, the disease caused by the coronavirus.

The solution turns to the body’s natural defenses, where there is a “small subset of gamma delta T cells” that act as the body’s first line of defense against viral infection.

By harvesting donor cells from patients who have successfully fought viral infection, where their immune systems have expanded to prevent infection again, doctors can infuse these cells into others to boost immunity .

T cells differ from normal immune cells in that they identify invaders in the body by detecting the unusual metabolism of the virus, as opposed to identifying exotic protrusions on the surface of the cells.

There are now over 38,000 cases of coronavirus in the UK, with over 3,600 deaths. World scientific community desperate for virus treatment and vaccine

There are now over 38,000 cases of coronavirus in the UK, with over 3,600 deaths. Global scientific community desperate for virus treatment and vaccine

LEAVE A REPLY

Please enter your comment!
Please enter your name here